SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3MEF - Registration statement to add securities to prior Form F-3 registration [Rule 462(b)]:
SEC Accession No. 0001193125-18-052654
Filing Date
2018-02-21
Accepted
2018-02-21 21:39:46
Documents
5
Effectiveness Date
2018-02-21

Document Format Files

Seq Description Document Type Size
1 F-3MEF d543438df3mef.htm F-3MEF 46170
2 EXHIBIT 5.1 d543438dex51.htm EX-5.1 23906
3 EXHIBIT 23.1 d543438dex231.htm EX-23.1 2929
4 GRAPHIC g543438g63h78.jpg GRAPHIC 5065
5 GRAPHIC g543438g72k73.jpg GRAPHIC 2765
  Complete submission text file 0001193125-18-052654.txt   85081
Mailing Address TUBORG BOULEVARD 5 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 5 HELLERUP G7 DK-2900 45 36 94 44 86
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: F-3MEF | Act: 33 | File No.: 333-223134 | Film No.: 18630435
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1